Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer

Current Urology Reports

Volumn 15, Issue 3, 2014, Pages

  Rais Bahrami, Soroush ^a   Turkbey, Baris ^a   Grant, Kinzya B ^a   Pinto, Peter A ^a   Choyke, Peter L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer Detection; Cancer Imaging; Magnetic Resonance Imaging; Prostate Biopsy

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC VALUE; DISEASE SURVEILLANCE; GLEASON SCORE; HUMAN; IMAGE GUIDED BIOPSY; MULTIPARAMETRIC NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; DIFFUSION WEIGHTED IMAGING; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84891900491     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-013-0387-9     Document Type: Article

References (55)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
2. Derweesh IH, Kupelian PA, Zippe C, Levin HS, Brainard J, Magi-Galluzzi C, et al. Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol. 2004;22(4):300-6. (Pubitemid 38993307)
3. Pinto PA, Chung PH, Rastinehad AR, Baccala Jr AA, Kruecker J, Benjamin CJ, et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol. 2011;186(4):1281-5.
4. Hegde JV, Mulkern RV, Panych LP, Fennessy FM, Fedorov A, Maier SE, et al. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. JMagn Reson Imaging. 2013;37(5):1035-54.
5. Bloch BN, Genega EM, Costa DN, Pedrosa I, Smith MP, Kressel HY, et al. Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI. Eur Radiol. 2012;22(10):2201-10.
6. Poon PY, McCallum RW, Henkelman MM, Bronskill MJ, Sutcliffe SB, Jewett MA, et al. Magnetic resonance imaging of the prostate. Radiology. 1985;154(1):143-9. (Pubitemid 15196302)
7. Dahms SE, Hohenfellner M, Linn JF, Eggersmann C, Haupt G, Thüroff JW. Retrovesical mass in men: pitfalls of differential diagnosis. J Urol. 1999;161:1244-8. (Pubitemid 29426126)
8. D'Amico AV, Schnall M, Whittington R, et al. Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. Urology. 1998;51:449-54. (Pubitemid 28136684)
9. Sella T, Schwartz LH, Swindle PW, et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology. 2004;231:379-85. (Pubitemid 38552892)
10. Tatli S, Mortele KJ, Breen EL, Bleday R, Silverman SG. Local staging of rectal cancer using combined pelvic phased-array and endorectal coil MRI. J Magn Reson Imaging. 2006;23:534-40.
11. .• Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology. 2007;243(1):28-53. Excellent review on multi-disciplinary imaging approach for prostate cancer. (Pubitemid 46579693)
12. Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA. Hulsbergen-van de Kaa CA, Scheenen T, Barentsz JO. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology. 2011;259(2):453-61.
13. Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology. 2011;261(1):46-66.
14. .• Turkbey B, Mani H, Shah V, et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol. 2011;186:1818-24. Important correlative study for multi-parametric prostate MRI since a patient specific customized mold is used for processing radical prostatectomy specimens.
15. Hegde JV, Mulkern RV, Panych LP, et al. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013;37:1035-54.
16. Engelbrecht MR, Puech P, Colin P, Akin O, Lemaître L, Villers A. Multimodality magnetic resonance imaging of prostate cancer. J Endourol. 2010;24(5):677-84.
17. Zakian KL, Eberhardt S, Hricak H, et al. Transition zone prostate cancer: metabolic characteristics at 1HMR spectroscopic imaging-initial results. Radiology. 2003;229:241-7. (Pubitemid 37152131)
18. Turkbey B, Choyke PL. Multiparametric MRI and prostate cancer diagnosis and risk stratification. Curr Opin Urol. 2012;22:310-5.
19. Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad A, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL. Can Multi-parametric MRI Identify Prostate Cancer Patients who are Candidates for Active Surveillance? Radiology. 2013;268:144-52.
20. Engelhard K, Hollenbach HP, Kiefer B, Winkel A, Goeb K, Engehausen D. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol. 2006;16:1237-43. (Pubitemid 43834709)
21. Zangos S, Melzer A, Eichler K, et al. MR-compatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions. Radiology. 2011;259:903-10.
22. .• Hambrock T, Hoeks C. Hulsbergen-van de Kaa C, et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol. 2012;61:177-84.
23. Kasivisvanathan V, Dufour R, Moore CM, et al. Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol. 2013;189:860-6.
24. Delongchamps NB, Peyromaure M, Schull A, et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol. 2013;189:493-9.
25. .• Pinto PA, Chung PH, Rastinehad AR, et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol. 2011;186:1281-5. One of the early studies, which compare TRUS/MRI fusion guided biopsy with systemic biopsy.
26. Beyersdorff D, Winkel A, Hamm B, Lenk S, Loening SA, Taupitz M. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology. 2005;234:576-81. (Pubitemid 40139933)
27. Haffner J, Lemaitre L, Puech P, et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int. 2011;108:E171-8.
28. Park BK, Park JW, Park SY, et al. Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. AJR Am J Roentgenol. 2011;197:W876-81.
29. Puech P, Rouvière O, Renard-Penna R, Villers A, Devos P, Colombel M, et al. Prostate Cancer Diagnosis: Multiparametric MR-targeted Biopsy with Cognitive and Transrectal US-MR Fusion Guidance versus Systematic Biopsy - Prospective Multicenter Study. Radiology. 2013;268(2):461-9.
30. Rais-Bahrami S, SiddiquiMM, Turkbey B, Stamatakis L, Logan J, Hoang AN, et al. Usefulness of Multiparametric Magnetic Resonance Imaging Suspicion Levels in Detecting Prostate Cancer. J Urol. 2013. doi:10.1016/j.juro.2013.05.052.
31. Sonn GA, Natarajan S, Margolis DJ, et al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol. 2013;189:86-91.
32. SiddiquiMM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, et al. Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy. Eur Urol. 2013. doi:10.1016/j.eururo.2013.05.059.
33. Vourganti S, Rastinehad A, Yerram NK, Nix J, Volkin D, Hoang A, et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol. 2012;188(6):2152-7.
34. Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. Value of Targeted Prostate Biopsy Using Magnetic Resonance-Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen. Eur Urol. 2013. doi:10.1016/j.eururo.2013.03.025.
35. Roethke M, Anastasiadis AG, Lichy M, et al. MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol. 2012;30:213-8.
36. Franiel T, Stephan C, Erbersdobler A, et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding-multiparametric MR imaging for detection and biopsy planning. Radiology. 2011;259:162-72.
37. Komai Y, Numao N, Yoshida S, et al. High Diagnostic Ability of Multiparametric Magnetic Resonance Imaging to Detect Anterior Prostate Cancer Missed by Transrectal 12-Core Biopsy. J Urol. 2013;190:867-73
38. Ouzzane A, Puech P, Lemaitre L, Leroy X, Nevoux P, Betrouni N, et al. Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. Urology. 2011;78(6):1356-62.
39. Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, et al. Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla. BJU Int. 2012;110(11 Pt B):E694-700.
40. Walton-Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, et al. Can MR-US Fusion Biopsy Improve Cancer Detection in Enlarged Prostates? J Urol. 2013. doi:10.1016/j.juro. 2013.05.118.
41. Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120.
42. Andriole GL, Crawford ED, Grubb 3rd RL, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostatecancer screening trial. N Engl J Med. 2009;360(13):1310-9.
43. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. ERSPC Investigators. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012;366(11):981-90.
44. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367(3):203-13. doi:10.1056/NEJMoa1113162.
45. Villers A, Puech P. When and How Should Magnetic Resonance Imaging be Used in Evaluation of the Patient with Prostate Cancer or Increased Prostate Specific Antigen? J Urol. 2013. doi:10.1016/j.juro.2013.08.014.
46. Villers A, Marliere F, Ouzzane A, Puech P, Lemaître L. MRI in addition to or as a substitute for prostate biopsy: the clinician's point of view. Diagn Interv Imaging. 2012;93(4):262-7.
47. Fütterer JJ. MR imaging in local staging of prostate cancer. Eur J Radiol. 2007;63:328.
48. Soylu FN, Eggener S, Oto A. Local staging of prostate cancer with MRI. Diagn Interv Radiol. 2012;18(4):365-73.
49. Soylu FN, Peng Y, Jiang Y, Wang S, Schmid-Tannwald C, Sethi I, et al. Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology. 2013;267(3):797-806.
50. Jeong IG, Lim JH, You D, Kim MH, Choi HJ, Kim JK, et al. Incremental Value of Magnetic Resonance Imaging for Clinically High Risk Prostate Cancer: A Large Single institution Experience of 922 Radical Prostatectomies. J Urol. 2013. doi:10.1016/j.juro.2013.06.035.
51. Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, et al. Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int. 2012;110(11 Pt B):E783-8.
52. Somford DM, Hamoen EH, Fütterer JJ, van Basten JP. Hulsbergen-van de Kaa CA, Vreuls W, van Oort IM, Vergunst H, Kiemeney LA, Barentsz JO, Witjes JA. The Predictive Value of Endorectal 3 Tesla Multiparametric Magnetic Resonance Imaging for Extraprostatic Extension in Patients with Low, Intermediate and High Risk Prostate Cancer. J Urol. 2013;190:1728.
53. Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology. 2013;268(1):144-52.
54. Stamatakis L, Siddiqui MM, Nix JW, Logan J, Rais-Bahrami S, Walton-Diaz A, et al. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer. 2013. doi:10.1002/cncr.28216.
55. Ouzzane A, Puech P, Villers A. MRI and surveillance. Curr Opin Urol. 2012;22(3):231-6.